[Pharmacological basis of the treatment of shock].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000818:Animals; D002986:Clinical Trials as Topic; D006439:Hemodynamics; D006801:Humans; D007263:Infusions, Parenteral; D012769:Shock / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology / Q000628:therapy; D013565:Sympatholytics / Q000627:therapeutic use; D014149:Tranquilizing Agents / Q000627:therapeutic use; D014655:Vascular Resistance / Q000187:drug effects; D014662:Vasoconstrictor Agents / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D013565:Sympatholytics; D014149:Tranquilizing Agents; D014662:Vasoconstrictor Agents
Bases pharmacologiques du traitement du choc.